Nonstructural protein σ1s mediates reovirus-induced cell cycle arrest and apoptosis

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12967-12979

  Boehme, Karl W ^a,b   Hammer, Katharina ^c,d   Tollefson, William C ^c,e   Konopka Anstadt, Jennifer L ^c   Kobayashi, Takeshi ^c,f   Dermody, Terence S ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e LOUISIANA STATE UNIVERSITY   (United States)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN SIGMA 1S; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE CLUSTER; GENETIC ENGINEERING; GENETIC LINKAGE; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REOVIRUS INFECTION; REVERSE GENETICS; STOP CODON; SURFACE CHARGE; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS VIRULENCE; WILD TYPE;

AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE; HUMANS; MAMMALIAN ORTHOREOVIRUS 3; MICE; REOVIRIDAE INFECTIONS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84887198717     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02080-13     Document Type: Article

References (87)

1. Roulston A, Marcellus RC, Branton PE. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577-628.
2. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS. 2010. Pannexin 1 channels mediate 'findme' signal release and membrane permeability during apoptosis. Nature 467:863-867.
3. Cullen SP, Henry CM, Kearney CJ, Logue SE, Feoktistova M, Tynan GA, Lavelle EC, Leverkus M, Martin SJ. 2013. Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells. Mol. Cell 49:1034-1048.
4. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS. 2009. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282-286.
5. Dermody TS, Parker J, Sherry B. 2013. Orthoreovirus. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2, p 1304-1346. Lippincott Williams & Wilkins, Philadelphia, PA.
6. Dichter MA, Weiner HL. 1984. Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism. Ann. Neurol. 16:603-610.
7. Tardieu M, Weiner HL. 1982. Viral receptors on isolated murine and human ependymal cells. Science 215:419-421.
8. Tyler KL, McPhee DA, Fields BN. 1986. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 233:770-774.
9. Tyler KL, Squier MKT, Brown AL, Pike B, Willis D, Oberhaus SM, Dermody TS, Cohen JJ. 1996. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis:role of the S1 and M2genes. J. Virol. 70:7984-7991.
10. Morrison LA, Sidman RL, Fields BN. 1991. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc. Natl. Acad. Sci. U.S.A. 88:3852-3856.
11. Weiner HL, Drayna D, Averill DR, Jr, Fields BN. 1977. Molecular basis of reovirus virulence:role of the S1 gene. Proc. Natl. Acad. Sci. U.S.A. 74:5744-5748.
12. Weiner HL, Powers ML, Fields BN. 1980. Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin. J. Infect. Dis. 141:609-616.
13. Tyler KL, Squier MK, Rodgers SE, Schneider SE, Oberhaus SM, Grdina TA, Cohen JJ, Dermody TS. 1995. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein σ1. J. Virol. 69:6972-6979.
14. McCrae MA, Joklik WK. 1978. The nature of the polypeptide encoded by each of the ten double-stranded RNA segments of reovirus type 3. Virology 89:578-593.
15. Mustoe TA, Ramig RF, Sharpe AH, Fields BN. 1978. Genetics of reovirus: identification of the dsRNA segments encoding the polypeptides of the μ and σ size classes. Virology 89:594-604.
16. Sarkar G, Pelletier J, Bassel-Duby R, Jayasuriya A, Fields BN, Sonenberg N. 1985. Identification of a new polypeptide coded by reovirus gene S1. J. Virol. 54:720-725.
17. Weiner HL, Ault KA, Fields BN. 1980. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J. Immunol. 124:2143-2148.
18. Danthi P, Hansberger MW, Campbell JA, Forrest JC, Dermody TS. 2006. JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J. Virol. 80:1261-1270.
19. Coffey CM, Sheh A, Kim IS, Chandran K, Nibert ML, Parker JS. 2006. Reovirus outer capsid protein μ1 induces apoptosis and associates with lipid droplets, endoplasmic reticulum, and mitochondria. J. Virol. 80: 8422-8438.
20. Danthi P, Coffey CM, Parker JS, Abel TW, Dermody TS. 2008. Independent regulation of reovirus membrane penetration and apoptosis by the μ1 φ domain. PLoS Pathog. 4:e1000248. doi:10.1371/journal.ppat .1000248.
21. Danthi P, Pruijssers AJ, Berger AK, Holm GH, Zinkel SS, Dermody TS. 2010. Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog. 6:e1000980. doi:10.1371/journal.ppat.1000980.
22. Kim JW, Lyi SM, Parrish CR, Parker JS. 2011. A proapoptotic peptide derived from reovirus outer capsid protein μ1 has membranedestabilizing activity. J. Virol. 85:1507-1516.
23. Wisniewski ML, Werner BG, Hom LG, Anguish LJ, Coffey CM, Parker JS. 2011. Reovirus infection or ectopic expression of outer capsid protein μ1 induces apoptosis independently of the cellular proapoptotic proteins Bax and Bak. J. Virol. 85:296-304.
24. Cashdollar LW, Chmelo RA, Wiener JR, Joklik WK. 1985. Sequences of the S1 genes of the three serotypes of reovirus. Proc. Natl. Acad. Sci. U.S.A. 82:24-28.
25. Ernst H, Shatkin AJ. 1985. Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc. Natl. Acad. Sci. U.S.A. 82:48-52.
26. Cenatiempo Y, Twardowski T, Shoeman R, Ernst H, Brot N, Weissbach H, Shatkin AJ. 1984. Two initiation sites detected in the small s1 species of reovirus mRNA by dipeptide synthesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 81:1084-1088.
27. Dermody TS, Nibert ML, Bassel-Duby R, Fields BN. 1990. Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J. Virol. 64:4842-4850.
28. Hoyt CC, Bouchard RJ, Tyler KL. 2004. Novel nuclear herniations induced by nuclear localization of a viral protein. J. Virol. 78:6360-6369.
29. 2/M cell cycle arrest results from inhibition of p34cdc2. J. Virol. 75:7429-7434.
30. 2/M cell cycle arrest requires σ1s and occurs in the absence of apoptosis. J. Virol. 74:9562-9570.
31. Hoyt CC, Richardson-Burns SM, Goody RJ, Robinson BA, Debiasi RL, Tyler KL. 2005. Nonstructural protein σ1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J. Virol. 79:2743-2753.
32. Rodgers SE, Connolly JL, Chappell JD, Dermody TS. 1998. Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a σ1s-null mutant. J. Virol. 72:8597-8604.
33. Chappell JD, Gunn VL, Wetzel JD, Baer GS, Dermody TS. 1997. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein σ1. J. Virol. 71:1834-1841.
34. Connolly JL, Barton ES, Dermody TS. 2001. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J. Virol. 75:4029-4039.
35. Barton ES, Youree BE, Ebert DH, Forrest JC, Connolly JL, Valyi-Nagy T, Washington K, Wetzel JD, Dermody TS. 2003. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J. Clin. Invest. 111:1823-1833.
36. Boehme KW, Frierson JM, Konopka JL, Kobayashi T, Dermody TS. 2011. The reovirus σ1s protein is a determinant of hematogenous but not neural virus dissemination in mice. J. Virol. 85:11781-11790.
37. Boehme KW, Guglielmi KM, Dermody TS. 2009. Reovirus nonstructural protein σ1s is required for establishment of viremia and systemic dissemination. Proc. Natl. Acad. Sci. U.S.A. 106:19986-19991.
38. Antar AAR, Konopka JL, Campbell JA, Henry RA, Perdigoto AL, Carter BD, Pozzi A, Abel TW, Dermody TS. 2009. Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe 5:59-71.
39. Kobayashi T, Antar AAR, Boehme KW, Danthi P, Eby EA, Guglielmi KM, Holm GH, Johnson EM, Maginnis MS, Naik S, Skelton WB, Wetzel JD, Wilson GJ, Chappell JD, Dermody TS. 2007. A plasmidbased reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1:147-157.
40. Virgin HW, Bassel-Duby IVR, Fields BN, Tyler KL. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
41. Furlong DB, Nibert ML, Fields BN. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:246-256.
42. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39:791-810.
43. Yao K, Vakharia VN. 1998. Generation of infectious pancreatic necrosis virus from cloned cDNA. J. Virol. 72:8913-8920.
44. Dove B, Brooks G, Bicknell K, Wurm T, Hiscox JA. 2006. Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication. J. Virol. 80:4147-4156.
45. Bodkin DK, Fields BN. 1989. Growth and survival of reovirus in intestinal tissue:role of the L2 and S1 genes. J. Virol. 63:1188-1193.
46. Bodkin DK, Nibert ML, Fields BN. 1989. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J. Virol. 63:4676-4681.
47. Nibert ML, Chappell JD, Dermody TS. 1995. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved σ1 protein. J. Virol. 69:5057-5067.
48. Sperka T, Wang J, Rudolph KL. 2012. DNA damage checkpoints in stem cells, ageing and cancer. Nat. Rev. Mol. Cell Biol. 13:579-590.
49. Turnell AS, Grand RJ. 2012. DNA viruses and the cellular DNA-damage response. J. Gen. Virol. 93:2076-2097.
50. Baer A, Austin D, Narayanan A, Popova T, Kainulainen M, Bailey C, Kashanchi F, Weber F, Kehn-Hall K. 2012. Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J. Biol. Chem. 287:7399-7410.
51. 2/M cell cycle arrest and host cellular protein translation shutoff involve activation of p53-dependent pathways. J. Virol. 84:7683-7694.
52. Kornitzer D, Sharf R, Kleinberger T. 2001. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J. Cell Biol. 154:331-344.
53. Kim S, Park SY, Yong H, Famulski JK, Chae S, Lee JH, Kang CM, Saya H, Chan GK, Cho H. 2008. HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 27:3457-3464.
54. Heilman DW, Green MR, Teodoro JG. 2005. The anaphase promoting complex:a critical target for viral proteins and anti-cancer drugs. Cell Cycle 4:560-563.
55. Liu Y, Rusinol A, Sinensky M, Wang Y, Zou Y. 2006. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J. Cell Sci. 119:4644-4649.
56. Manju K, Muralikrishna B, Parnaik VK. 2006. Expression of diseasecausing lamin A mutants impairs the formation of DNA repair foci. J. Cell Sci. 119:2704-2714.
57. Dehay C, Kennedy H. 2007. Cell-cycle control and cortical development. Nat. Rev. Neurosci. 8:438-450.
58. Clarke P, Beckham JD, Leser JS, Hoyt CC, Tyler KL. 2009. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J. Virol. 83:6161-6170.
59. Clarke P, Meintzer SM, Gibson S, Widmann C, Garrington TP, Johnson GL, Tyler KL. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74:8135-8139.
60. Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL. 2001. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene 20:6910-6919.
61. Kominsky DJ, Bickel RJ, Tyler KL. 2002. Reovirus-induced apoptosis requires both death receptor-and mitochondrial-mediated caspasedependent pathways of cell death. Cell Death Differ. 9:926-933.
62. Richardson-Burns SM, Kominsky DJ, Tyler KL. 2002. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J. Neurovirol. 8:365-380.
63. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, Schnell F, Nusrat A, Parkos CA, Dermody TS. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451.
64. Danthi P, Kobayashi T, Holm GH, Hansberger MW, Abel TW, Dermody TS. 2008. Reovirus apoptosis and virulence are regulated by host cell membrane-penetration efficiency. J. Virol. 82:161-172.
65. Kaufer S, Coffey CM, Parker JS. 2012. The cellular chaperone hsc70 is specifically recruited to reovirus viral factories independently of its chaperone function. J. Virol. 86:1079-1089.
66. Fleeton M, Contractor N, Leon F, Wetzel JD, Dermody TS, Kelsall B. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200:235-245.
67. Jubelin G, Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R, Nougayrede JP, Zumbihl R, Givaudan A, Escoubas JM, Oswald E. 2009. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One 4:e4855. doi:10.1371/journal.pone.0004855.
68. Oswald E, Nougayrede JP, Taieb F, Sugai M. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8:83-91.
69. Rubin DH, Kornstein MJ, Anderson AO. 1985. Reovirus serotype 1 intestinal infection:a novel replicative cycle with ileal disease. J. Virol. 53:391-398.
70. Planz O, Pleschka S, Oesterle K, Berberich-Siebelt F, Ehrhardt C, Stitz L, Ludwig S. 2003. Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex. J. Virol. 77:11186-11192.
71. Kannan RP, Hensley LL, Evers LE, Lemon SM, McGivern DR. 2011. Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J. Virol. 85:7989-8001.
72. Bian T, Gibbs JD, Orvell C, Imani F. 2012. Respiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathway. PLoS One 7:e38052. doi:10.1371/journal.pone.0038052.
73. 1 phase. J. Virol. 78:5658-5669.
74. He Y, Xu K, Keiner B, Zhou J, Czudai V, Li T, Chen Z, Liu J, Klenk HD, Shu YL, Sun B. 2010. Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J. Virol. 84:12832-12840.
75. McChesney MB, Altman A, Oldstone MB. 1988. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. J. Immunol. 140:1269-1273.
76. McChesney MB, Kehrl JH, Valsamakis A, Fauci AS, Oldstone MB. 1987. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J. Virol. 61:3441-3447.
77. Dyson N, Howley PM, Munger K, Harlow E. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
78. Adair RA, Roulstone V, Scott KJ, Morgan R, Nuovo GJ, Fuller M, Beirne D, West EJ, Jennings VA, Rose A, Kyula J, Fraser S, Dave R, Anthoney DA, Merrick A, Prestwich R, Aldouri A, Donnelly O, Pandha H, Coffey M, Selby P, Vile R, Toogood G, Harrington K, Melcher AA. 2012. Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci. Transl. Med. 4:138ra177.
79. Karapanagiotou EM, Roulstone V, Twigger K, Ball M, Tanay M, Nutting C, Newbold K, Gore ME, Larkin J, Syrigos KN, Coffey M, Thompson B, Mettinger K, Vile RG, Pandha HS, Hall GD, Melcher AA, Chester J, Harrington KJ. 2012. Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin. Cancer Res. 18:2080-2089.
80. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC. 1998. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol. 140:637-645.
81. Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G, Branton PE. 1998. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. J. Virol. 72:7144-7153.
82. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:2324-2331.
83. 2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-6711.
84. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
85. 2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:6859-6864.
86. Rogel ME, Wu LI, Emerman M. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
87. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. 2005. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1:e4. doi:10.1371/journal.ppat.0010004.